Professor and Division Chief UT Southwestern Medical School Dallas, Texas, United States
Disclosure(s):
Adam Yopp, MD: Genentech/Roche: Consultant (Ongoing)
Attendees will gain an understanding of mechanisms of action of new immunotherapies and the impact these interventions have had in recent practice changing clinical trials for patients with GI, HPB, Skin, and Breast malignancies.
